0.95HKD
789.00 MHKD
6.56 BHKD
507.55 M
About HUTCHMED (CHINA) LIMITED
Sector
CEO
Wei Guo Su
Headquarters
Hong Kong
Website
Employees (FY)
1.99 K
Founded
2000
ISIN
KYG4672N1198
FIGI
BBG011J3CPR1
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.
HCM Learning experiencePlaying Trading Simulator:
Big time rookie mistake.
Bought 350 shares at $41.71 on 3JAN18. Price was falling.
Same day bought 500 shares at $39.93 in order to dilute my buying price.
I began studying the chart and saw my mistake.
On 5JAN18 I sold my shares using a trailing stop of 10 cents.
It exe
Tracking HCMI've been a long term holder of HCM since 2009. They are also listed on the FTSE AIM 100 LSE:HCM.
They have outperformed the NASDAQ BIOTECHNOLOGY INDEX INDEX:NBI
Now would be a good place to exit.
I will continue to hold for now, i am not trading this. It's included in my long term portfolio.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 13 is 27.55 HKD — it has increased by 2.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUTCHMED (CHINA) LIMITED stocks are traded under the ticker 13.
HUTCHMED (CHINA) LIMITED is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
13 stock is 3.35% volatile and has beta coefficient of 1.93. Check out the list of the most volatile stocks — is HUTCHMED (CHINA) LIMITED there?
One year price forecast for HUTCHMED (CHINA) LIMITED has a max estimate of 70.50 HKD and a min estimate of 26.65 HKD.
13 earnings for the last quarter are 1.49 HKD per share, whereas the estimation was −0.82 HKD resulting in a 282.69% surprise. The estimated earnings for the next quarter are −0.86 HKD per share. See more details about HUTCHMED (CHINA) LIMITED earnings.
HUTCHMED (CHINA) LIMITED revenue for the last quarter amounts to 4.18 B HKD despite the estimated figure of 2.41 B HKD. In the next quarter revenue is expected to reach 2.49 B HKD.
Yes, you can track HUTCHMED (CHINA) LIMITED financials in yearly and quarterly reports right on TradingView.
13 stock has fallen by 1.25% compared to the previous week, the month change is a 1.10% rise, over the last year HUTCHMED (CHINA) LIMITED has showed a 5.96% increase.
13 net income for the last quarter is −529.92 M HKD, while the quarter before that showed 1.32 B HKD of net income which accounts for −140.11% change. Track more HUTCHMED (CHINA) LIMITED financial stats to get the full picture.
Today HUTCHMED (CHINA) LIMITED has the market capitalization of 22.65 B, it has increased by 0.19% over the last week.
No, 13 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 13 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUTCHMED (CHINA) LIMITED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 1.99 K employees. See our rating of the largest employees — is HUTCHMED (CHINA) LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUTCHMED (CHINA) LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUTCHMED (CHINA) LIMITED stock shows the buy signal. See more of HUTCHMED (CHINA) LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HUTCHMED (CHINA) LIMITED future price: according to them, 13 price has a max estimate of 70.51 HKD and a min estimate of 26.64 HKD. Read a more detailed HUTCHMED (CHINA) LIMITED forecast: see what analysts think of HUTCHMED (CHINA) LIMITED and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUTCHMED (CHINA) LIMITED EBITDA is 210.10 M HKD, and current EBITDA margin is 3.05%. See more stats in HUTCHMED (CHINA) LIMITED financial statements.